# Cryogenic and Stasis Technology: Freezing Time

## Overview

Cryogenic preservation — the cooling of biological tissue to temperatures where metabolic processes effectively stop — has been a viable medical technology since the 2080s. In 2200, cryogenic stasis is used for three purposes: medical preservation (keeping critically injured patients viable until treatment is available), long-duration transit (passengers on interplanetary missions), and the controversial practice of elective stasis — wealthy individuals who choose to be frozen and awakened at a future date.

## Medical Cryogenics

Medical cryopreservation is the most common application: a patient whose injuries exceed immediate treatment capability is cooled to 4°C (clinical hypothermia) to reduce metabolic demand, then to -80°C (deep preservation) if transfer to a treatment facility will take more than 24 hours. The cooling process uses cryoprotectant solutions that prevent ice crystal formation — the primary cause of cellular damage during freezing.

Modern cryoprotectants are remarkably effective: a patient preserved at -80°C can be revived after months with minimal tissue damage, provided the cooling and warming procedures are executed correctly. The revival process is the critical phase — uneven warming produces thermal stress that damages cells. Medical cryorevival uses precisely controlled microwave warming that raises tissue temperature uniformly across the body.

Sterling-Nakamura's medical cryogenics division processes approximately 500 medical preservation cases annually in GLMZ — primarily severe trauma cases that require specialized treatment available only at facilities outside the city, transported via hyperloop in portable cryogenic units.

## Elective Stasis

The controversial application: individuals who choose to be preserved for future revival. Motivations vary — terminal patients awaiting future cures, individuals who want to experience the future, and (most commonly) wealthy clients who view stasis as a form of time travel. Elective stasis is available from Sterling-Nakamura at a cost of Φ500,000 for preservation and Φ10,000/year for ongoing storage and monitoring.

There are approximately 2,000 individuals in elective stasis in GLMZ, stored in Sterling-Nakamura's cryogenic facility in the Thornfield campus. The facility is secured to military standards — the liability exposure of 2,000 frozen clients represents billions of Φ in legal obligations, and the reputational damage of a facility failure would be catastrophic.

## The Legal Complications

Individuals in cryogenic stasis occupy a legal gray zone. They are not dead — their tissue is viable and revival is possible. They are not alive — they have no metabolic activity, no consciousness, and no capacity for legal action. The Meridian Charter does not address the status of cryopreserved individuals, which has produced a series of legal challenges:

**Property rights**: Does a preserved individual retain ownership of their assets, or do those assets pass to heirs as though the individual had died? Current precedent: retained, with a court-appointed trustee managing assets during stasis.

**Consent**: Can a preserved individual consent to being revived, or does the revival decision belong to whoever contracted the preservation? Current precedent: revival requires either the individual's pre-stasis written instructions or the consent of their designated legal representative.

**Identity continuity**: Is a revived individual the same legal person as the one who was preserved? Current precedent: yes, but the question has never been tested for preservation periods exceeding 20 years. The philosophical implications of awakening decades in the future — in a world that has moved on, where the person's context, relationships, and relevance have changed — are similar to the questions raised by consciousness upload and synthetic personhood.